What happened
President Donald Trump yesterday used a press conference on autism to offer pregnant women unfounded and in some cases discredited medical advice on Tylenol and vaccinations. Health officials at the briefing said the Food and Drug Administration would approve leucovorin, a form of vitamin B currently approved to treat chemotherapy side effects, as a treatment for some children with “autistic symptoms,” and announced a new push to research environmental factors behind the complex brain disorder.
Who said what
“Don’t take Tylenol,” Trump advised pregnant women. “Fight like hell not to take it” unless they “can’t tough it out” or have an extremely high fever. The FDA was “far more measured” in a note to physicians yesterday, noting “accurately” that no “causal relationship” has been established between autism and acetaminophen use during pregnancy, The New York Times said, and that the matter is “an ongoing area of scientific debate.”
Trump, who “struggled to pronounce ‘acetaminophen’” in his warnings, “defied the careful guidance offered by some in the row of scientific advisers who stood behind him,” The Wall Street Journal said. The “tableau was reminiscent of the last time Trump played the role of physician-in-chief,” during the Covid-19 pandemic, except this time his “advisers nodded or kept their faces straight” instead of “openly” rolling their eyes.
Some studies have “raised the possibility” of a link between prenatal Tylenol and autism, said The Associated Press, “but many others haven’t found that concern.” Acetaminophen is the “only over-the-counter drug approved to treat pain relief and fevers during pregnancy,” Politico said, and maternal medical organizations agree that the serious risk to mother and fetus from untreated fevers is worse than any theoretical risk from Tylenol. Trump’s remarks were the “saddest display of a lack of evidence, rumors, recycling old myths, lousy advice, outright lies and dangerous advice I have ever witnessed by anyone in authority,” New York University bioethicist Art Caplan said to the AP.
What next?
The FDA said it would approve leucovorin for the subset of autistic children with “cerebral folate deficiency,” based on the findings of small-scale studies, and order acetaminophen makers to change their label to “reflect evidence suggesting” use during pregnancy “may be associated with an increased risk of neurological conditions such as autism and ADHD in children.”
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
The dazzling coral gardens of Raja AmpatThe Week Recommends Region of Indonesia is home to perhaps the planet’s most photogenic archipelago.
-
Trump’s White House ballroom: a threat to the republic?Talking Point Trump be far from the first US president to leave his mark on the Executive Mansion, but to critics his remodel is yet more overreach
-
‘Never more precarious’: the UN turns 80The Explainer It’s an unhappy birthday for the United Nations, which enters its ninth decade in crisis
-
Climate change is getting under our skinUnder the radar Skin conditions are worsening because of warming temperatures
-
Is this the end of ultraprocessed foods?Today's Big Question California law and the MAHA movement are on the same track
-
Bluetoothing: the phenomenon driving HIV spike in FijiUnder the Radar ‘Blood-swapping’ between drug users fuelling growing health crisis on Pacific island
-
Can TrumpRx really lower drug prices?Today’s Big Question Pfizer’s deal with Trump sent drugmaker stocks higher
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
‘Nightmare bacteria’ are rapidly spreadingUnder the radar The infections are largely resistant to antibiotics
-
Kissing bug disease has a growing presence in the USThe explainer The disease has yielded a steady stream of cases in the last 10 years
